公开(公告)号：US20200216819A1

公开(公告)日：2020-07-09

申请号：US16731846

申请日：2019-12-31

Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

Inventor： Edward CLARK ,  Jay Wesley CHAPLIN

IPC: C12N7/00 ,  A61K39/29 ,  A61K47/68 ,  C07K16/28 ,  A61K39/385 ,  A61K39/12

Abstract: The present invention provides compositions of CD180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.

公开(公告)号：US20190144834A1

公开(公告)日：2019-05-16

申请号：US16245459

申请日：2019-01-11

Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

Inventor： Edward CLARK ,  Jay Wesley CHAPLIN

IPC: C12N7/00 ,  A61K39/29 ,  A61K39/385 ,  A61K47/68 ,  C07K16/28 ,  A61K39/12

Abstract: The present invention provides compositions of CD180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.